Evidence map›Paper›PMID 39949720›Full record

ArticleFrontiers in cellular and infection microbiology2025

Distribution of

Rui Zhao, Bingyu Du, Lingling Hu, Chenxi Li, Fen Xue, Xing Wang, Changhong Jiang, Jinghua Wang, Yanfeng Zhao

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rui Zhao *Clinical Microbiology Laboratory, Shanghai Center for Clinical Laboratory, Shanghai, China.
Bingyu Du *Laboratory Medicine Center, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Lingling Hu *Laboratory Medicine Center, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Chenxi LiLaboratory Medicine Center, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Fen XueLaboratory Medicine Center, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Xing WangDepartment of Laboratory Medicine, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Changhong JiangDepartment of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jinghua WangClinical Microbiology Laboratory, Shanghai Center for Clinical Laboratory, Shanghai, China.
Yanfeng ZhaoLaboratory Medicine Center, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methicillin-resistant Methods: A polymerase chain reaction (PCR) assay was developed to detect the presence of the Results: A total of 26 STs were identified, with notable prevalence in five epidemic clones: ST59, ST5, and ST764. The prevalence of the Discussion: Notably, forty-seven (61%) MRSA BSI strains were multidrug-resistant, with the majority exhibiting resistance to penicillin, erythromycin, and clindamycin. Major MRSA clones in southern China include ST59, ST5, ST764, and ST398. In this study,

Indexed as

BacteremiaBacterial ProteinsMembrane Transport ProteinsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsChinaGenes, BacterialGenotypeHumansMaleMicrobial Sensitivity TestsMolecular EpidemiologyMultilocus Sequence TypingNuclear ProteinsPolymerase Chain ReactionAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsmupA protein, Staphylococcus aureusNuclear ProteinsqacA protein, Staphylococcus aureusVirulence Factorsbloodstream infectionsMLSTMRSAmupAqacA/BsasXsequence type

Identifiers

PMID39949720
PMCPMC11821609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.